72 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Conjunctivitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: Placebo
2 Not yet recruiting Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: PVP-I 0.6%;   Drug: Placebo
3 Recruiting Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Vancomycin 1.1%;   Drug: Placebo
4 Not yet recruiting Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: PVP-I 0.6%;   Drug: Placebo
5 Recruiting A Study of ADX-102 in Subjects With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: ADX-102 Ophthalmic Drops (0.5%);   Drug: ADX-102 Ophthalmic Drops (0.1%);   Drug: Vehicle of ADX-102 Ophthalmic Drops
6 Recruiting Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
Conditions: Epiphora;   Conjunctivitis
Interventions: Device: Perforated Punctal plugs;   Procedure: Crawford tube insertion;   Device: Crawford lacrimal tube
7 Recruiting Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Intervention: Drug: Alcaftadine Ophthalmic Solution 0.25%
8 Recruiting Reducing Adenoviral Patient Infected Days
Conditions: Conjunctivitis;   Adenoviral Conjunctivitis
Interventions: Drug: Betadine 5%;   Drug: Artificial Tears
9 Not yet recruiting Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Condition: Adenoviral Conjunctivitis
Interventions: Drug: Iota-Carrageenan;   Drug: Carmellose
10 Recruiting A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: genteal gel
11 Recruiting Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
Condition: Allergy
Intervention: Drug: Oralair
12 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
13 Recruiting Seasonal Differences in Nasal Mucus Proteome and Impact of Immunotherapy
Condition: Allergic Rhinoconjunctivitis
Intervention: Biological: Immunotherapy
14 Recruiting Efficacy and Safety of LAIS® Mites Sublingual Tablets
Condition: Allergic Conditions
Intervention: Drug: LAIS®
15 Recruiting Topical Tacrolimus in Vernal Keratoconjunctivitis
Condition: Vernal Keratoconjunctivitis
Intervention: Drug: Topical tacrolimus
16 Recruiting Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Condition: Hay Fever
Interventions: Biological: Placebo solution;   Biological: gpASIT+TM
17 Not yet recruiting Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy
Conditions: Rhinitis;   Rhinoconjunctivitis
Interventions: Biological: MM09 Mannosylated 5.000 subcutaneous;   Biological: MM09 Mannosylated 10.000 subcutaneous;   Biological: MM09 Mannosylated 30.000 subcutaneous;   Biological: MM09 Mannosylated 50.000 subcutaneous;   Biological: MM09 Mannosylated 5.000 sublingual;   Biological: MM09 Mannosylated 10.000 sublingual;   Biological: MM09 Mannosylated 30.000 sublingual;   Biological: MM09 Mannosylated 50.000 sublingual;   Biological: Subcutaneous placebo;   Biological: Sublingual placebo
18 Not yet recruiting Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Conditions: Rhinitis;   Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 5.000 subcutaneous;   Biological: MG56 Mannosylated 10.000 subcutaneous;   Biological: MG56 Mannosylated 30.000 subcutaneous;   Biological: MG56 Mannosylated 50.000 subcutaneous;   Biological: MG56 Mannosylated 5.000 sublingual;   Biological: MG56 Mannosylated 10.000 sublingual;   Biological: MG56 Mannosylated 30.000 sublingual;   Biological: MG56 Mannosylated 50.000 sublingual;   Biological: Subcutaneous placebo;   Biological: Sublingual placebo
19 Recruiting Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
Conditions: Rhinitis;   Rhinoconjunctivitis;   Asthma
Interventions: Biological: DP/MG/14-1;   Biological: DP/MG/14-2
20 Not yet recruiting Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice
Conditions: Allergic Rhinitis;   Rhinoconjunctivitis;   Asthma
Intervention: Biological: Allergovac Poliplus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.